Literature DB >> 10224236

Caspase activation by BCR cross-linking in immature B cells: differential effects on growth arrest and apoptosis.

A Brás1, A Ruiz-Vela, G González de Buitrago, C Martinez-A.   

Abstract

The B cell lymphoma WEHI-231 has been used as a model to study immature B cell tolerance, based on its capacity to undergo growth arrest and programmed cell death on B cell receptor (BCR) cross-linking. Using this model to identify the molecular mechanisms underlying these processes, we found that BCR cross-linking results in the selective activation of caspase 7/Mch3, but not of the other two members of the CPP32 family, caspase 2/Nedd2 and caspase 3/CPP32. This was evidenced by the induction of proteolytic activity against the substrate for the CPP32 subfamily of caspases (z-DVED-AMC) in vitro, as well as PARP proteolysis in vivo and by the processing of the 35 kDa Mch3 into a 32 kDa species, which was later further proteolyzed. The general caspase inhibitor z-VAD-fmk, but not the CPP32 family inhibitor Ac-DEVD-CHO, blocked anti- micro-induced apoptosis, indicating that a caspase not belonging to the CPP32-like family is also implicated in anti- micro-triggered apoptosis. In contrast, z-VAD-fmk was not able to counteract growth arrest induced by anti- micro treatment, suggesting that caspase activation is not necessary for induction of growth arrest. Neither of the inhibitors prevented Mch3 processing; however, z-VAD-fmk prevented proteolysis of the p32 subunit, suggesting that further processing of this subunit is associated with apoptosis. Bcl-2 overexpression prevented anti- micro induction of CPP32-like activity and apoptosis, and blocked further processing of the Mch3 p32 subunit. In contrast, CD40 stimulation completely blocked the appearance of the p32 subunit in addition to blocking CPP32-like activity and apoptosis induced by BCR cross-linking. Moreover, only CD40 stimulation was able to prevent anti- micro-induced growth arrest, which was correlated with inhibition of retinoblastoma and of cyclin A down-regulation. In splenic B cells, Mch3 is also specifically proteolyzed ex vivo after induction of apoptosis by BCR cross-linking, demonstrating the specific involvement of caspase-7/Mch3 in apoptosis induced in B cell tolerance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10224236     DOI: 10.1096/fasebj.13.8.931

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

1.  A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas.

Authors:  R Marches; E S Vitetta; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

2.  DIO-1 is a gene involved in onset of apoptosis in vitro, whose misexpression disrupts limb development.

Authors:  D García-Domingo; E Leonardo; A Grandien; P Martínez; J P Albar; J C Izpisúa-Belmonte; C Martínez-A
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

3.  B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression.

Authors:  Jonathan M Irish; June H Myklebust; Ash A Alizadeh; Roch Houot; Jeff P Sharman; Debra K Czerwinski; Garry P Nolan; Ronald Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-11       Impact factor: 11.205

4.  The molecular mechanism in activation-induced cell death of an Ag-reactive B cell clone.

Authors:  T Hamano; T Iwasaki; A Ogata; N Hashimoto; E Kakishita
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

5.  Transplanted long-term cultured pre-BI cells expressing calpastatin are resistant to B cell receptor-induced apoptosis.

Authors:  A Ruiz-Vela; F Serrano; M A González; J L Abad; A Bernad; M Maki; C Martínez-A
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

6.  Thy28 partially prevents apoptosis induction following engagement of membrane immunoglobulin in WEHI-231 B lymphoma cells.

Authors:  Hiroko Toyota; Xiao-Zhou Jiang; Hideki Asakura; Junichiro Mizuguchi
Journal:  Cell Mol Biol Lett       Date:  2011-12-02       Impact factor: 5.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.